Overview
US Stock Market
Technology
Financial
Real Estate
Energy
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Utilities
Other Symbols
Currencies
Major
Minor
America
Europe
Asia
Cryptocurrencies
Metals
Indexes
Commodities
Charts
WidgetsGANX: Gain Therapeutics Inc
GANX exchange rate has changed by -2.28% for today. During the day, the instrument was traded at a low of 2.55 and at a high of 2.68.
Follow Gain Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GANX News
- Gain Therapeutics reports 81% reduction in Parkinson’s biomarker
- Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)
- Gain Therapeutics (GANX) Upgraded to Buy: Here's Why
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%
- Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
- Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy
- H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data
- Gain Therapeutics files prospectus supplement for $35.5 million stock offering
- Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know
- Gain Therapeutics stock rating reiterated at Buy by H.C. Wainwright
- Gain Therapeutics reports preliminary Phase 1b data for Parkinson’s drug GT-02287
- Gain Therapeutics reports positive early data from Parkinson’s trial
- Gain Therapeutics extends Phase 1b Parkinson’s treatment study
- Gain Therapeutics extends Phase 1b Parkinson’s drug trial to 12 months
- H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock at $8 price target
- BTIG lowers Gain Therapeutics stock price target to $9 on biomarker data timing
- Gain Therapeutics stock falls after announcing public offering
- Gain Therapeutics stock advances as Phase 1b trial enrollment exceeds expectations
Frequently Asked Questions
What is GANX stock price today?
Gain Therapeutics Inc stock is priced at 2.57 today. It trades within 2.55 - 2.68, yesterday's close was 2.63, and trading volume reached 613. The live price chart of GANX shows these updates.
Does Gain Therapeutics Inc stock pay dividends?
Gain Therapeutics Inc is currently valued at 2.57. Dividend policy depends on the company, while investors also watch 34.55% and USD. View the chart live to track GANX movements.
How to buy GANX stock?
You can buy Gain Therapeutics Inc shares at the current price of 2.57. Orders are usually placed near 2.57 or 2.87, while 613 and -4.10% show market activity. Follow GANX updates on the live chart today.
How to invest into GANX stock?
Investing in Gain Therapeutics Inc involves considering the yearly range 1.41 - 4.34 and current price 2.57. Many compare -1.15% and 45.20% before placing orders at 2.57 or 2.87. Explore the GANX price chart live with daily changes.
What are Gain Therapeutics Inc stock highest prices?
The highest price of Gain Therapeutics Inc in the past year was 4.34. Within 1.41 - 4.34, the stock fluctuated notably, and comparing with 2.63 helps spot resistance levels. Track Gain Therapeutics Inc performance using the live chart.
What are Gain Therapeutics Inc stock lowest prices?
The lowest price of Gain Therapeutics Inc (GANX) over the year was 1.41. Comparing it with the current 2.57 and 1.41 - 4.34 shows potential long-term entry points. Watch GANX moves on the chart live for more details.
When did GANX stock split?
Gain Therapeutics Inc has gone through stock splits historically. These changes are visible in , 2.63, and 34.55% after corporate actions.
- Previous Close
- 2.63
- Open
- 2.68
- Bid
- 2.57
- Ask
- 2.87
- Low
- 2.55
- High
- 2.68
- Volume
- 613
- Daily Change
- -2.28%
- Month Change
- -1.15%
- 6 Months Change
- 45.20%
- Year Change
- 34.55%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- 1.7%
- Prev
- 4.9%
- Act
- Fcst
- -0.1%
- Prev
- -1.9%
- Act
- Fcst
- 222 K
- Prev
- 212 K
- Act
- Fcst
- 1.836 M
- Prev
- 1.833 M
- Act
- Fcst
- Prev